On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio Farma, a leading biopharmaceutical company in Indonesia, for the supply, local production and technology licensing in respect of the CoronaVac, Sinovacﾒs inactivated vaccine candidate against COVID-19.